Zynerba Pharmaceuticals Inc. (ZYNE) NASDAQ

$1.32 -0.01 (-0.75%)

Market Cap: $60.85M

As of 08/17/22 10:15 AM EDT. Market open.

(ZYNE)

Zynerba Pharmaceuticals Inc. (ZYNE) NASDAQ

$1.32 -0.01 (-0.75%)

Market Cap: $60.85M

As of 08/17/22 10:15 AM EDT. Market open.

Zynerba Pharmaceuticals is the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. Zynerba Pharmaceuticals is committed to improving the lives of patients and their families living with severe, chronic health conditions including Fragile X syndrome, autism spectrum disorder, 22q11.2 deletion syndrome, and a ... read more

Zynerba Pharmaceuticals is the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. Zynerba Pharmaceuticals is committed to improving the lives of patients and their families living with severe, chronic health conditions including Fragile X syndrome, autism spectrum disorder, 22q11.2 deletion syndrome, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Armando Anido
Full Time Employees
26
CEO Compensation (Base)
$568,218
CEO Compensation (Total)
$2M
URL
Address
80 W. Lancaster Avenue, Suite 300, Pennsylvania, Devon, 19333.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Armando Anido
Full Time Employees
26
CEO Compensation (Base)
$568,218
CEO Compensation (Total)
$2M
Address
80 W. Lancaster Avenue, Suite 300, Pennsylvania, Devon, 19333.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$1.33
Previous Close
$1.33
Days Range
$1.30 - $1.37
52 week range
$0.84 - $4.65
Volume
158,550
Avg. Volume (30 days)
507,955
Market Cap
$60.85M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
45,753,079
Open
$1.33
Previous Close
$1.33
Days Range
$1.30 - $1.37
52 week range
$0.84 - $4.65
Volume
158,550
Avg. Volume (30 days)
507,955
Market Cap
$60.85M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
45,753,079

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ZYNERBA PHARMACEUTICALS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Sebree Terri B President Jul 19, 2022 Sale $1.10 8,281 9,109 367,865 Jul 20, 2022, 04:08 PM
Rosenberger Brian VP, Commercial & Business Dev. Jul 19, 2022 Sale $1.10 4,289 4,718 107,511 Jul 20, 2022, 04:06 PM
Fickenscher James E Chief Financial Officer Jul 19, 2022 Sale $1.10 6,013 6,614 172,505 Jul 20, 2022, 04:05 PM
ANIDO ARMANDO Chairman & CEO Jul 19, 2022 Sale $1.10 11,899 13,089 611,688 Jul 20, 2022, 04:05 PM
KISNER DANIEL L Director Jun 14, 2022 Sale $1.01 40 40 28,069 Jun 16, 2022, 09:53 PM
FEDERICI WILLIAM J Director Jun 14, 2022 Sale $1.01 40 40 28,069 Jun 16, 2022, 09:52 PM
Stephenson Pamela Director Jun 14, 2022 Sale $1.01 40 40 28,069 Jun 16, 2022, 09:51 PM
MOCH KENNETH I Director Jun 14, 2022 Sale $1.01 40 40 28,069 Jun 16, 2022, 09:50 PM
COOPER WARREN D Director Jun 14, 2022 Sale $1.01 40 40 28,069 Jun 16, 2022, 09:49 PM
Butler John P. Director Jun 14, 2022 Sale $1.01 53 54 33,056 Jun 16, 2022, 09:48 PM
Butler John P. Director Aug 22, 2018 Buy $6.43 5,000 32,153 5,000 Aug 22, 2018, 04:39 PM
ANIDO ARMANDO Chairman & Chief Exec. Officer Aug 06, 2018 Buy $5.96 15,000 89,423 352,512 Aug 07, 2018, 04:32 PM
Hanlon Suzanne M. Sec, VP & General Counsel Aug 06, 2018 Buy $5.80 3,800 22,048 43,693 Aug 07, 2018, 04:30 PM
Sebree Terri B President Aug 06, 2018 Buy $5.79 3,800 22,013 182,546 Aug 07, 2018, 04:29 PM
Fickenscher James E Chief Financial Officer Aug 06, 2018 Buy $5.97 8,518 50,842 20,718 Aug 07, 2018, 04:28 PM
RAPP MICHAEL 10% Owner May 30, 2018 Buy $10.45 5,885 61,498 1,500,000 May 31, 2018, 09:26 AM
RAPP MICHAEL 10% Owner May 02, 2018 Buy $10.46 15,000 156,945 1,494,115 May 02, 2018, 05:38 PM
RAPP MICHAEL 10% Owner Mar 22, 2018 Buy $9.28 10,000 92,790 1,479,115 Mar 23, 2018, 09:30 AM
RAPP MICHAEL 10% Owner Jan 02, 2018 Buy $12.99 15,000 194,847 1,469,115 Jan 03, 2018, 06:05 AM
RAPP MICHAEL 10% Owner Oct 23, 2017 Buy $9.94 25,745 255,795 1,454,115 Oct 23, 2017, 07:25 PM
RAPP MICHAEL 10% Owner Oct 20, 2017 Buy $9.78 30,000 293,538 1,428,370 Oct 23, 2017, 07:25 PM
RAPP MICHAEL 10% Owner Oct 19, 2017 Buy $9.59 44,255 424,405 1,398,370 Oct 23, 2017, 07:25 PM
ANIDO ARMANDO Chairman & Chief Exec. Officer May 15, 2017 Buy $19.57 1,500 29,355 337,512 May 16, 2017, 08:50 AM
ANIDO ARMANDO Chairman & Chief Exec. Officer May 12, 2017 Buy $19.76 3,500 69,160 336,012 May 16, 2017, 08:50 AM
Fickenscher James E Chief Financial Officer May 12, 2017 Buy $19.82 5,200 103,064 12,200 May 16, 2017, 08:50 AM
RAPP MICHAEL 10% Owner Dec 29, 2016 Buy $15.85 10,000 158,500 1,354,115 Dec 29, 2016, 09:54 PM
Fickenscher James E Chief Financial Officer Dec 07, 2016 Buy $14.03 4,000 56,120 7,000 Dec 08, 2016, 02:01 PM
Fickenscher James E Chief Financial Officer Dec 06, 2016 Buy $14.15 3,000 42,450 3,000 Dec 08, 2016, 02:01 PM
Hanlon Suzanne M. Sec, General Counsel & VP HR Aug 05, 2015 Buy $17.92 3,000 53,760 3,000 Aug 17, 2016, 02:19 PM
Hanlon Suzanne M. Sec, General Counsel & VP HR Aug 16, 2016 Sale $10.53 3,000 31,590 0 Aug 17, 2016, 02:19 PM
BARON RICHARD A Chief Financial Officer Sep 11, 2015 Option Exercise $3.98 15,957 63,509 15,957 Sep 15, 2015, 01:48 PM
HARRISON THOMAS L Director Aug 10, 2015 Buy $14.00 12,500 175,000 12,500 Aug 12, 2015, 11:48 AM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Sebree Terri B President 07/19/2022 9,109
Rosenberger Brian VP, Commercial & Business Dev. 07/19/2022 4,718
Fickenscher James E Chief Financial Officer 07/19/2022 6,614
ANIDO ARMANDO Chairman & CEO 07/19/2022 13,089
KISNER DANIEL L Director 06/14/2022 40
FEDERICI WILLIAM J Director 06/14/2022 40
Stephenson Pamela Director 06/14/2022 40
MOCH KENNETH I Director 06/14/2022 40
COOPER WARREN D Director 06/14/2022 40
Butler John P. Director 06/14/2022 54
Butler John P. Director 08/22/2018 32,153
ANIDO ARMANDO Chairman & Chief Exec. Officer 08/06/2018 89,423
Hanlon Suzanne M. Sec, VP & General Counsel 08/06/2018 22,048
Sebree Terri B President 08/06/2018 22,013
Fickenscher James E Chief Financial Officer 08/06/2018 50,842
RAPP MICHAEL 10% Owner 05/30/2018 61,498
RAPP MICHAEL 10% Owner 05/02/2018 156,945
RAPP MICHAEL 10% Owner 03/22/2018 92,790
RAPP MICHAEL 10% Owner 01/02/2018 194,847
RAPP MICHAEL 10% Owner 10/23/2017 255,795
RAPP MICHAEL 10% Owner 10/20/2017 293,538
RAPP MICHAEL 10% Owner 10/19/2017 424,405
ANIDO ARMANDO Chairman & Chief Exec. Officer 05/15/2017 29,355
ANIDO ARMANDO Chairman & Chief Exec. Officer 05/12/2017 69,160
Fickenscher James E Chief Financial Officer 05/12/2017 103,064
RAPP MICHAEL 10% Owner 12/29/2016 158,500
Fickenscher James E Chief Financial Officer 12/07/2016 56,120
Fickenscher James E Chief Financial Officer 12/06/2016 42,450
Hanlon Suzanne M. Sec, General Counsel & VP HR 08/05/2015 53,760
Hanlon Suzanne M. Sec, General Counsel & VP HR 08/16/2016 31,590
BARON RICHARD A Chief Financial Officer 09/11/2015 63,509
HARRISON THOMAS L Director 08/10/2015 175,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2022
03/31/2022
1.38%
1Q
06/30/2022
12/31/2021
4.07%
2Q
06/30/2022
09/30/2021
4.95%
3Q
06/30/2022
06/30/2021
6.56%
4Q
06/30/2022
03/31/2021
1.98%
5Q
Load More

Period of Report: 06/30/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2022
1.38%
1Q
12/31/2021
4.07%
2Q
09/30/2021
4.95%
3Q
06/30/2021
6.56%
4Q
03/31/2021
1.98%
5Q
Load More